We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sponsors Face New Trial Transparency Requirements in EU, Starting Jan. 1
Sponsors Face New Trial Transparency Requirements in EU, Starting Jan. 1
October 9, 2014
Starting Jan. 1, drugmakers that sell products in the EU will have to make publicly available clinical trial data used to support marketing authorization.